glp-1 euglycemic dka Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence New therapeutic agents for type

M., & Wood, J

Sue Decotiis, M.D., a triple board-certified physician in internal medicine, antiaging medicine, and obesity medicine, who leads a weight-loss practice in Scarsdale, NY

This increase suggests heightened awareness of the potential risks associated with GLP-1 drugs like Ozempic

She said the goal of the project was to increase the number of GLP-1 prescriptions dispensed and the number of patients enrolled with the specialty pharmacy by 10% in 1 year

While there is no direct pharmacokinetic interaction between GLP-1/GIP receptor agonists and sertraline, both medications have overlapping side effect profiles that may be additive when used together